A multicentre evaluation of a new surgical technique for urethral bulking in the treatment of genuine stress incontinence.
This prospective study assesses the surgeon and patient acceptability of a new implantation device for transurethral Macroplastique injection, as well as the safety and effectiveness of the technique. Ten women with genuine stress incontinence were recruited at each of four participating urogynaecological centres. Treatment was performed in an outpatient or day case setting and follow up took place at six weeks and three months after treatment. Those in whom treatment had failed were offered re-treatment. The operator acceptance of the device was rated as excellent or acceptable in 95% after the first treatment and 100% after re-treatment. Urethral insertions were rated acceptable in 92.5%. Pain was scored as mild to moderate in 89% of all insertions. The overall success rate was 74.3% at three months with an implantation rate of 1.35 which appears to be comparable to published endoscopic data. We have concluded from this study that the Macroplastique implantation device is safe to use and provides simplified, yet effective alternative to the endoscopic implantation of urethral bulking agents.
Henalla
S M
SM
Barnsley District General Hospital, South Yorkshire, The Netherlands.
Hall
V
V
Duckett
J R
JR
Link
C
C
Usman
F
F
Tromans
P M
PM
van Veggel
L
L
D005260:Female; D006801:Humans; D017060:Patient Satisfaction; D011446:Prospective Studies; D016896:Treatment Outcome; D014522:Urethral Diseases / Q000601:surgery*; D014550:Urinary Incontinence, Stress / Q000601:surgery*; D013520:Urologic Surgical Procedures / Q000295:instrumentation*